High IDL causes: Difference between revisions
Jump to navigation
Jump to search
Ochuko Ajari (talk | contribs) |
Ochuko Ajari (talk | contribs) |
||
| Line 131: | Line 131: | ||
===Causes in Alphabetical Order=== | ===Causes in Alphabetical Order=== | ||
*[[apolipoprotein E|Apolipoprotein E deficiency]] | *[[apolipoprotein E|Apolipoprotein E deficiency]] | ||
*[[Chronic renal failure]] | *[[Chronic renal failure]] <ref name="pmid10412757">{{cite journal| author=Nishizawa Y, Shoji T, Tabata T, Inoue T, Morii H| title=Effects of lipid-lowering drugs on intermediate-density lipoprotein in uremic patients. | journal=Kidney Int Suppl | year= 1999 | volume= 71 | issue= | pages= S134-6 | pmid=10412757 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10412757 }} </ref> | ||
*[[hepatic lipase|Decreased hepatic triglyceride lipase]] | *[[hepatic lipase|Decreased hepatic triglyceride lipase]]<ref name="pmid9350691">{{cite journal| author=Nishizawa Y, Shoji T, Kawagishi T, Morii H| title=Atherosclerosis in uremia: possible roles of hyperparathyroidism and intermediate density lipoprotein accumulation. | journal=Kidney Int Suppl | year= 1997 | volume= 62 | issue= | pages= S90-2 | pmid=9350691 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9350691 }} </ref> | ||
*[[Diabetes mellitus type 2]] | *[[Diabetes mellitus type 2]] <ref name="pmid8497453">{{cite journal| author=Durrington PN| title=Diabetes, hypertension and hyperlipidaemia. | journal=Postgrad Med J | year= 1993 | volume= 69 Suppl 1 | issue= | pages= S18-25; discussion S25-9 | pmid=8497453 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8497453 }} </ref> | ||
*[[Diabetic nephropathy]] | *[[Diabetic nephropathy]]<ref name="pmid11395040">{{cite journal| author=Shoji T, Emoto M, Kawagishi T, Kimoto E, Yamada A, Tabata T et al.| title=Atherogenic lipoprotein changes in diabetic nephropathy. | journal=Atherosclerosis | year= 2001 | volume= 156 | issue= 2 | pages= 425-33 | pmid=11395040 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11395040 }} </ref> | ||
*[[Familial alphalipoprotein deficiency]] | *[[Familial alphalipoprotein deficiency]] | ||
*[[Glycogen storage disease type 1a]] | *[[Glycogen storage disease type 1a]]<ref name="pmid17407002">{{cite journal| author=Geberhiwot T, Alger S, McKiernan P, Packard C, Caslake M, Elias E et al.| title=Serum lipid and lipoprotein profile of patients with glycogen storage disease types I, III and IX. | journal=J Inherit Metab Dis | year= 2007 | volume= 30 | issue= 3 | pages= 406 | pmid=17407002 | doi=10.1007/s10545-007-0485-2 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17407002 }} </ref><ref name="pmid3130454">{{cite journal| author=Levy E, Thibault LA, Roy CC, Bendayan M, Lepage G, Letarte J| title=Circulating lipids and lipoproteins in glycogen storage disease type I with nocturnal intragastric feeding. | journal=J Lipid Res | year= 1988 | volume= 29 | issue= 2 | pages= 215-26 | pmid=3130454 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=3130454 }} </ref> | ||
*[[Hyperparathyroidism]] | *[[Hyperparathyroidism]] <ref name="pmid9350691">{{cite journal| author=Nishizawa Y, Shoji T, Kawagishi T, Morii H| title=Atherosclerosis in uremia: possible roles of hyperparathyroidism and intermediate density lipoprotein accumulation. | journal=Kidney Int Suppl | year= 1997 | volume= 62 | issue= | pages= S90-2 | pmid=9350691 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9350691 }} </ref> | ||
*[[Hypocalcemia]] | *[[Hypocalcemia]] <ref name="pmid9350691">{{cite journal| author=Nishizawa Y, Shoji T, Kawagishi T, Morii H| title=Atherosclerosis in uremia: possible roles of hyperparathyroidism and intermediate density lipoprotein accumulation. | journal=Kidney Int Suppl | year= 1997 | volume= 62 | issue= | pages= S90-2 | pmid=9350691 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9350691 }} </ref> | ||
*[[metabolic syndrome|Reaven X syndrome]] | *[[metabolic syndrome|Reaven X syndrome]] | ||
Revision as of 18:29, 10 October 2013
|
Intermediate Density Lipoprotein Microchapters |
|
Clinical Correlation |
|---|
|
Treatment |
|
Case Studies |
|
High IDL causes On the Web |
|
American Roentgen Ray Society Images of High IDL causes |
|
Directions to Hospitals Treating Intermediate density lipoprotein |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ogheneochuko Ajari, MB.BS, MS [2]
Overview
High IDL Causes
Life Threatening Causes
Common Causes
Causes by Organ System
| Cardiovascular | No underlying causes |
| Chemical/Poisoning | No underlying causes |
| Dental | No underlying causes |
| Dermatologic | No underlying causes |
| Drug Side Effect | No underlying causes |
| Ear Nose Throat | No underlying causes |
| Endocrine | No underlying causes |
| Environmental | No underlying causes |
| Gastroenterologic | No underlying causes |
| Genetic | No underlying causes |
| Hematologic | No underlying causes |
| Iatrogenic | No underlying causes |
| Infectious Disease | No underlying causes |
| Musculoskeletal/Orthopedic | No underlying causes |
| Neurologic | No underlying causes |
| Nutritional/Metabolic | No underlying causes |
| Obstetric/Gynecologic | No underlying causes |
| Oncologic | No underlying causes |
| Ophthalmologic | No underlying causes |
| Overdose/Toxicity | No underlying causes |
| Psychiatric | No underlying causes |
| Pulmonary | No underlying causes |
| Renal/Electrolyte | No underlying causes |
| Rheumatology/Immunology/Allergy | No underlying causes |
| Sexual | No underlying causes |
| Trauma | No underlying causes |
| Urologic | No underlying causes |
| Miscellaneous | No underlying causes |
Causes in Alphabetical Order
- Apolipoprotein E deficiency
- Chronic renal failure [1]
- Decreased hepatic triglyceride lipase[2]
- Diabetes mellitus type 2 [3]
- Diabetic nephropathy[4]
- Familial alphalipoprotein deficiency
- Glycogen storage disease type 1a[5][6]
- Hyperparathyroidism [2]
- Hypocalcemia [2]
- Reaven X syndrome
References
- ↑ Nishizawa Y, Shoji T, Tabata T, Inoue T, Morii H (1999). "Effects of lipid-lowering drugs on intermediate-density lipoprotein in uremic patients". Kidney Int Suppl. 71: S134–6. PMID 10412757.
- ↑ 2.0 2.1 2.2 Nishizawa Y, Shoji T, Kawagishi T, Morii H (1997). "Atherosclerosis in uremia: possible roles of hyperparathyroidism and intermediate density lipoprotein accumulation". Kidney Int Suppl. 62: S90–2. PMID 9350691.
- ↑ Durrington PN (1993). "Diabetes, hypertension and hyperlipidaemia". Postgrad Med J. 69 Suppl 1: S18–25, discussion S25-9. PMID 8497453.
- ↑ Shoji T, Emoto M, Kawagishi T, Kimoto E, Yamada A, Tabata T; et al. (2001). "Atherogenic lipoprotein changes in diabetic nephropathy". Atherosclerosis. 156 (2): 425–33. PMID 11395040.
- ↑ Geberhiwot T, Alger S, McKiernan P, Packard C, Caslake M, Elias E; et al. (2007). "Serum lipid and lipoprotein profile of patients with glycogen storage disease types I, III and IX". J Inherit Metab Dis. 30 (3): 406. doi:10.1007/s10545-007-0485-2. PMID 17407002.
- ↑ Levy E, Thibault LA, Roy CC, Bendayan M, Lepage G, Letarte J (1988). "Circulating lipids and lipoproteins in glycogen storage disease type I with nocturnal intragastric feeding". J Lipid Res. 29 (2): 215–26. PMID 3130454.